These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 30877519)

  • 21. MicroRNAs as biomarkers for psychiatric disorders with a focus on autism spectrum disorder: Current progress in genetic association studies, expression profiling, and translational research.
    Hu Y; Ehli EA; Boomsma DI
    Autism Res; 2017 Jul; 10(7):1184-1203. PubMed ID: 28419777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of Nogo: a key strategy to increase regeneration, plasticity and functional recovery of the lesioned central nervous system.
    Buchli AD; Schwab ME
    Ann Med; 2005; 37(8):556-67. PubMed ID: 16338758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNAs: Roles in Regulating Neuroinflammation.
    Gaudet AD; Fonken LK; Watkins LR; Nelson RJ; Popovich PG
    Neuroscientist; 2018 Jun; 24(3):221-245. PubMed ID: 28737113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNAs in the brain: it's regulatory role in neuroinflammation.
    Thounaojam MC; Kaushik DK; Basu A
    Mol Neurobiol; 2013 Jun; 47(3):1034-44. PubMed ID: 23315269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-155: An Important Regulator of Neuroinflammation.
    Zingale VD; Gugliandolo A; Mazzon E
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. microRNAs in Cerebrovascular Disease.
    Volný O; Kašičková L; Coufalová D; Cimflová P; Novák J
    Adv Exp Med Biol; 2015; 888():155-95. PubMed ID: 26663183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role and regulatory mechanism of microRNA mediated neuroinflammation in neuronal system diseases.
    Zhang J; Li A; Gu R; Tong Y; Cheng J
    Front Immunol; 2023; 14():1238930. PubMed ID: 37637999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondria-associated microRNAs in rat hippocampus following traumatic brain injury.
    Wang WX; Visavadiya NP; Pandya JD; Nelson PT; Sullivan PG; Springer JE
    Exp Neurol; 2015 Mar; 265():84-93. PubMed ID: 25562527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-based interventions in aberrant cell cycle diseases: Therapeutic strategies for cancers, central nervous system disorders and comorbidities.
    Tang X; Ren Y; Zeng W; Feng X; He M; Lv Y; Li Y; He Y
    Biomed Pharmacother; 2024 Aug; 177():116979. PubMed ID: 38906026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between the chemokine receptor CCR5 and microglia in neurological disorders: consequences of targeting CCR5 on neuroinflammation, neuronal death and regeneration in a model of epilepsy.
    Louboutin JP; Strayer DS
    CNS Neurol Disord Drug Targets; 2013 Sep; 12(6):815-29. PubMed ID: 24047524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNAs show a wide diversity of expression profiles in the developing and mature central nervous system.
    Kapsimali M; Kloosterman WP; de Bruijn E; Rosa F; Plasterk RH; Wilson SW
    Genome Biol; 2007; 8(8):R173. PubMed ID: 17711588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-207/352 regulate lysosomal-associated membrane proteins and enzymes following ischemic stroke.
    Tao J; Liu W; Shang G; Zheng Y; Huang J; Lin R; Chen L
    Neuroscience; 2015 Oct; 305():1-14. PubMed ID: 26232047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-155 Deletion in Mice Overcomes Neuron-Intrinsic and Neuron-Extrinsic Barriers to Spinal Cord Repair.
    Gaudet AD; Mandrekar-Colucci S; Hall JC; Sweet DR; Schmitt PJ; Xu X; Guan Z; Mo X; Guerau-de-Arellano M; Popovich PG
    J Neurosci; 2016 Aug; 36(32):8516-32. PubMed ID: 27511021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metallothionein in the central nervous system: Roles in protection, regeneration and cognition.
    West AK; Hidalgo J; Eddins D; Levin ED; Aschner M
    Neurotoxicology; 2008 May; 29(3):489-503. PubMed ID: 18313142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategic approaches to regeneration of a damaged central nervous system.
    Okano H
    Cornea; 2011 Oct; 30 Suppl 1():S15-8. PubMed ID: 21912223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges and standardization of microRNA profiling in serum and cerebrospinal fluid in dogs suffering from non-infectious inflammatory CNS disease.
    Cirera S; Andersen-Ranberg EU; Langkilde S; Aaquist M; Gredal H
    Acta Vet Scand; 2019 Dec; 61(1):57. PubMed ID: 31796072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonconventional chemical inhibitors of microRNA: therapeutic scope.
    Jayaraj GG; Nahar S; Maiti S
    Chem Commun (Camb); 2015 Jan; 51(5):820-31. PubMed ID: 25328158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-10b-5p expression in Huntington's disease brain relates to age of onset and the extent of striatal involvement.
    Hoss AG; Labadorf A; Latourelle JC; Kartha VK; Hadzi TC; Gusella JF; MacDonald ME; Chen JF; Akbarian S; Weng Z; Vonsattel JP; Myers RH
    BMC Med Genomics; 2015 Mar; 8():10. PubMed ID: 25889241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-19b-3p Modulates Japanese Encephalitis Virus-Mediated Inflammation via Targeting RNF11.
    Ashraf U; Zhu B; Ye J; Wan S; Nie Y; Chen Z; Cui M; Wang C; Duan X; Zhang H; Chen H; Cao S
    J Virol; 2016 May; 90(9):4780-4795. PubMed ID: 26937036
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.